Navigation Links
Capitol chemistry: How Congress will alter the science landscape in 2014
Date:1/29/2014

The Congressional agenda for 2014 includes science issues with far-reaching implications for an array of issues including public health, job growth, pharmaceutical research and energy, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society. The mid-term elections occurring this fall, however, promise to complicate progress on key legislative efforts, already stymied by a bitter partisan atmosphere.

Among the topics that the article addresses is the modernization of the Toxic Substances Control Act, a law that governs commercial chemicals. In a rare bipartisan effort, policymakers from both sides of the aisle are helping refine legislation, which was introduced last year. As it gains bipartisan momentum, private sector interests are adding friction and could affect the strength of specific provisions. Other article highlights include forecasts for energy bills to address power plant emissions and nuclear waste disposal; science policy that could encourage research and development or make it more difficult; and consumer protection laws affecting dietary supplements and antibiotics.

In addition to bills with the most obvious ties to chemical research and businesses, the article notes that industry experts also must keep a keen eye on intertwined agricultural and international issues as well. For example, the farm bill could include provisions that affect pesticide use, and trade agreements have the potential to boost domestic job growth in the chemical industries.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Stanford expert brings climate change science to heated Capitol Hill
2. Biochemistry: Unspooling DNA from nucleosomal disks
3. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
4. Purdue professor to speak before Congress about nanotechnology in brain treatment research
5. ESMO 2012 Congress: A path for medical oncology innovations
6. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
7. International congress on behavior, animal husbandry and animal well-being in Vienna
8. 2016 International Congress of Entomology to be held in Orlando, Florida
9. Madidi conservationist wins award at World Conservation Congress
10. Noteworthy studies at the ESMO 2012 Congress
11. Majority of Americans doubt Congress and White House can avoid fiscal cliff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2018)... ... October 01, 2018 , ... Myoscience, ... and Chief Executive Officer. Mr. Still will also be joining the Company’s Board ... medical devices and diagnostics. He has extensive leadership experience in designing and implementing ...
(Date:9/29/2018)... ... September 29, 2018 , ... ReimbursementIQ is offering two-hour ... in-person briefings are expected to transform Medical Affairs, Market Access, and Marketing functions ... healthcare market—especially to individuals, employers, and other healthcare purchasers. , “Health ...
(Date:9/27/2018)... ... September 26, 2018 , ... The Rett Syndrome ... joined the organization in the role of Chief Scientific Officer and Chief Business ... Officer is transitioning to Chief Medical Officer. , The decision to expand ...
Breaking Biology News(10 mins):
(Date:9/13/2018)... ... 13, 2018 , ... Asymmetrex’s director, James L. Sherley, M.D., Ph.D., ... medicine, if we didn’t have the means to measure the number of drug molecules ... “Nowhere! And that is what’s holding up progress in stem cell medicine.” , “Can ...
(Date:9/12/2018)... ... September 11, 2018 , ... Sterlitech Corporation, a global leader ... membranes from Fluid Technology Solutions (FTS H2O) to their offering of filtration products. ... cellulose triacetate (CTA) material. The highly hydrophilic nature of the CTA FO membranes ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery ... a meeting of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ ... tools to study these emerging targets in a quest to find new treatments ...
(Date:9/7/2018)... ... 06, 2018 , ... Akadeum Life Sciences today announced it has appointed George ... and leader of numerous biotech companies. , He most recently served as president ... Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was a ...
Breaking Biology Technology: